Finally, co-delivery of two mRNA-encoded bsAbs (EGFR x CD3 and PD-L1 × 4-1BB) demonstrated synergistic tumor inhibition in a colorectal cancer model, highlighting the potential of multiplexed mRNA nanotherapies [94]. The gene discussed is EGFR; the disease is neoplasm.